| Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 229 | 2021 |
| Management of connective tissue diseases associated interstitial lung disease: a review of the published literature B Wallace, D Vummidi, D Khanna Current opinion in rheumatology 28 (3), 236-245, 2016 | 129 | 2016 |
| Predicting hospitalization and outpatient corticosteroid use in inflammatory bowel disease patients using machine learning AK Waljee, R Lipson, WL Wiitala, Y Zhang, B Liu, J Zhu, B Wallace, ... Inflammatory bowel diseases 24 (1), 45-53, 2018 | 104 | 2018 |
| Development and validation of machine learning models in prediction of remission in patients with moderate to severe Crohn disease AK Waljee, BI Wallace, S Cohen-Mekelburg, Y Liu, B Liu, K Sauder, ... JAMA network open 2 (5), e193721-e193721, 2019 | 75 | 2019 |
| Anti-tumour necrosis factor-α therapy and recurrent or new primary cancers in patients with inflammatory bowel disease, rheumatoid arthritis, or psoriasis and previous cancer … AK Waljee, PDR Higgins, CB Jensen, M Villumsen, SA Cohen-Mekelburg, ... The Lancet Gastroenterology & Hepatology 5 (3), 276-284, 2020 | 62 | 2020 |
| Prevalence of immunosuppressive drug use among commercially insured US adults, 2018-2019 BI Wallace, B Kenney, PN Malani, DJ Clauw, BK Nallamothu, AK Waljee JAMA Network Open 4 (5), e214920-e214920, 2021 | 59 | 2021 |
| Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases JS Hausmann, K Kennedy, JF Simard, JW Liew, JA Sparks, TT Moni, ... The Lancet Rheumatology 3 (10), e707-e714, 2021 | 46 | 2021 |
| Comparative efficacy and safety of targeted DMARDs for active psoriatic arthritis during induction therapy: a systematic review and network meta-analysis C Lu, BI Wallace, AK Waljee, W Fu, Q Zhang, Y Liu Seminars in Arthritis and Rheumatism 49 (3), 381-388, 2019 | 41 | 2019 |
| Patients with lupus with COVID-19: University of Michigan experience B Wallace, L Washer, W Marder, JM Kahlenberg Annals of the Rheumatic Diseases, 2020 | 40 | 2020 |
| COVID-19 Global Rheumatology Alliance. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Ann Rheum Dis 80 (9), 1137-1146, 2021 | 28 | 2021 |
| Reliability, validity and responsiveness to change of the Saint George’s Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis B Wallace, S Kafaja, DE Furst, VJ Berrocal, PA Merkel, JR Seibold, ... Rheumatology 54 (8), 1369-1379, 2015 | 28 | 2015 |
| Patterns of glucocorticoid prescribing and provider-level variation in a commercially insured incident rheumatoid arthritis population: a retrospective cohort study BI Wallace, P Lin, N Kamdar, M Noureldin, R Hayward, DA Fox, JR Curtis, ... Seminars in arthritis and rheumatism 50 (2), 228-236, 2020 | 20 | 2020 |
| Variability in glucocorticoid prescribing for rheumatoid arthritis and the influence of provider preference on long‐term use of glucocorticoids MD George, JF Baker, B Wallace, L Chen, Q Wu, F Xie, H Yun, JR Curtis Arthritis care & research 73 (11), 1597-1605, 2021 | 19 | 2021 |
| Performance of Gout Impact Scale in a longitudinal observational study of patients with gout B Wallace, D Khanna, C Aquino-Beaton, JA Singh, E Duffy, D Elashoff, ... Rheumatology 55 (6), 982-990, 2016 | 17 | 2016 |
| The association between nonsteroidal anti-inflammatory drug use and inflammatory bowel disease exacerbations: a true association or residual bias? S Cohen-Mekelburg, T Van, B Wallace, J Berinstein, X Yu, J Lewis, J Hou, ... Official journal of the American College of Gastroenterology| ACG 117 (11 …, 2022 | 15 | 2022 |
| Fibromyalgianess and glucocorticoid persistence among patients with rheumatoid arthritis BI Wallace, MN Moore, AC Heisler, LN Muhammad, J Song, DJ Clauw, ... Rheumatology 61 (4), 1556-1562, 2022 | 14 | 2022 |
| Evidence to support or guide glucocorticoid tapering in rheumatoid arthritis is lacking BI Wallace, DM Wallace, AK Waljee, DJ Clauw Annals of the Rheumatic Diseases 78 (12), 1733-1734, 2019 | 14 | 2019 |
| Correlation of fibromyalgia survey questionnaire and quantitative sensory testing among patients with active rheumatoid arthritis MN Moore, BI Wallace, J Song, LN Muhammad, AC Heisler, DJ Clauw, ... The Journal of rheumatology 49 (9), 1052-1057, 2022 | 13 | 2022 |
| Association of continuity of care with outcomes in US veterans with inflammatory bowel disease S Cohen-Mekelburg, SD Saini, SL Krein, TP Hofer, BI Wallace, ... JAMA Network Open 3 (9), e2015899-e2015899, 2020 | 13 | 2020 |
| Inflammatory bowel disease readmissions are associated with utilization and comorbidity S Cohen-Mekelburg, R Rosenblatt, B Wallace, N Shen, B Fortune, ... Am J Manag Care 25 (10), 474-81, 2019 | 13 | 2019 |
Akbar K. WaljeeProfessor, University of Michigan在 umich.edu 的电子邮件经过验证
